Singapore markets close in 21 minutes
Straits Times Index
3,301.08 +8.15 (+0.25%) Nikkei
38,236.07 -38.03 (-0.10%) Hang Seng
18,578.30 +102.38 (+0.55%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
65,396.67 +1,768.31 (+2.78%) CMC Crypto 200
1,404.86 +92.23 (+7.04%)
Wilmar International Limited (WLMIY)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
| Previous close | 23.67 |
| Open | 23.93 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 23.49 - 24.50 |
| 52-week range | 22.49 - 30.42 |
| Volume | |
| Avg. volume | 5,525 |
| Market cap | 14.989B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 9.84 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.26 (5.26%) |
| Ex-dividend date | 29 Apr 2024 |
| 1y target est | N/A |
- PR Newswire
Cerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders.
Cerecin Inc., a clinical-stage biotechnology company at the forefront of developing innovative neurotherapeutics, is pleased to announce the establishment of a Memorandum of Understanding (MOU) with A*STAR's Institute of Molecular and Cell Biology (IMCB). This collaboration aims to accelerate research and treatment initiatives for neurological disorders and diseases to enhance overall health and brain function.
© 2024 Yahoo. All rights reserved.